|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||38.84 - 39.17|
|52 Week Range||37.20 - 44.54|
|PE Ratio (TTM)||44.07|
|Dividend & Yield||1.99 (5.13%)|
|1y Target Est||N/A|
Perrigo (PRGO) gains an FDA consent for the OTC version of AstraZeneca's Nexium post the ongoing patent lawsuit settlement through an agreement.
Top Analyst Reports for Allergan, Ecolab & Exelon
Pfizer, GlaxoSmithKline, and Novo Nordisk all offer up temptingly high yields. Here's why they're worth putting on your radar.